Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Journal of Hepatocellular Carcinoma
Volume 11, 2024 - Issue
ORIGINAL RESEARCH
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma
, , , 
, , , , , , , , & show all
Yehia I Mohamed1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAhttps://orcid.org/0000-0002-5192-3804View further author information
https://orcid.org/0000-0002-5192-3804View further author information, , , Rikita I Hatia4 Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAhttps://orcid.org/0000-0003-2591-5963View further author information
https://orcid.org/0000-0003-2591-5963View further author information, , James C Yao1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAhttps://orcid.org/0000-0002-1875-3962View further author information
https://orcid.org/0000-0002-1875-3962View further author information, , , Hesham M Amin7 Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;8 MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USACorrespondence[email protected]
https://orcid.org/0000-0002-7973-6699View further author information
https://orcid.org/0000-0002-7973-6699View further author information & show all